Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Nectar Lifesciences Limited

Market Cap 180.66Cr 1.91Cr 1.68Cr 1.54Cr 1.45Cr 2.71Cr 2.75Cr 19Cr 7.18Cr 89Cr 7.16Cr 7.01Cr 308.09Cr P/E 2024
137x
P/E 2025 -4.53x
Enterprise Value 742.93Cr 7.84Cr 6.89Cr 6.35Cr 5.94Cr 11Cr 11Cr 76Cr 30Cr 364.52Cr 29Cr 29Cr 1.27TCr EV / Sales 2024
0.77x
EV / Sales 2025 0.64x
Free-Float
42.77%
Yield 2024 *
-
Yield 2025 -
1 day+1.22%
1 week-3.56%
Current month-6.43%
1 month-4.12%
3 months+11.70%
6 months-44.89%
Current year-39.98%
1 week 11.25
Extreme 11.25
12.24
1 month 11.05
Extreme 11.05
12.75
Current year 9.3
Extreme 9.3
20.9
1 year 9.3
Extreme 9.3
23.87
3 years 9.3
Extreme 9.3
56.5
5 years 9.3
Extreme 9.3
56.5
10 years 7.1
Extreme 7.1
56.5
Manager TitleAgeSince
Director of Finance/CFO 68 14/11/2022
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 27/06/1995
Director/Board Member 69 11/02/2019
Director/Board Member 75 21/09/2021
Date Insider Type Main position Quantity % Market Cap.
19/24/19Buy 4,00,000 0.1784%
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-3.56%-44.76%-38.03% 2.36Cr
+0.44%+3.07%+12.91%+88.58% 4.73TCr
+1.49%+2.84%+53.64%+102.01% 3.49TCr
+0.85%+6.97%-3.82%+41.40% 1.22TCr
-0.85%+3.91%+14.34%+96.32% 1.18TCr
+1.52%-0.57%+37.80%+122.46% 888.11Cr
+0.59%+0.17%+16.96%+41.10% 696.37Cr
+0.90%+4.47%+50.50%-12.96% 677.48Cr
-0.14%+1.80%+29.23%+237.02% 649.25Cr
+0.71%+2.14%-35.63%+0.19% 509.06Cr
Average +0.67%+1.97%+13.12%+67.81% 1.4TCr
Weighted average by Cap. +0.71%+3.08%+24.27%+86.99%

Financials

2024 2025
Net sales 1.68TCr 18Cr 16Cr 14Cr 13Cr 25Cr 26Cr 172.85Cr 67Cr 826.53Cr 67Cr 65Cr 2.87TCr 1.67TCr 18Cr 15Cr 14Cr 13Cr 25Cr 25Cr 171.39Cr 66Cr 819.56Cr 66Cr 65Cr 2.85TCr
Net income 5Cr 5L 5L 4L 4L 7L 8L 51.25L 19.84L 2.45Cr 19.79L 19.37L 8.52Cr -113.68Cr -1.2Cr -1.05Cr -97.14L -90.94L -1.7Cr -1.73Cr -12Cr -4.52Cr -56Cr -4.51Cr -4.41Cr -193.86Cr
Net Debt 615.24Cr 6.49Cr 5.71Cr 5.26Cr 4.92Cr 9.22Cr 9.38Cr 63Cr 24Cr 301.86Cr 24Cr 24Cr 1.05TCr 562.27Cr 5.94Cr 5.21Cr 4.8Cr 4.5Cr 8.43Cr 8.57Cr 58Cr 22Cr 275.88Cr 22Cr 22Cr 958.85Cr
Logo Nectar Lifesciences Limited
Nectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.
Employees
1,786
Date Price Change Volume
24/26/24 11.65 +1.22% 69,139
23/26/23 ₹11.51 -2.62% 1,36,920
22/26/22 ₹11.82 +3.32% 2,33,443
19/26/19 ₹11.44 -1.63% 1,31,033
18/26/18 ₹11.63 -3.73% 6,11,867
  1. Stock Market
  2. Stocks
  3. NECLIFE Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!